✦ LIBER ✦

Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer

✍ Scribed by Kakolyris, S; Kouroussis, Ch; Souglakos, J; Agelaki, S; Kalbakis, K; Vardakis, N; Vamvakas, L; Georgoulias, V

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage treatment of taxane-refractory a

✍ Kakolyris, S; Androulakis, N; Agelaki, S; Mavroudis, D; Souglakos, J; Vardakis, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Combination chemotherapy with irinotecan

✍ Jie Luo; Ying Xu; Songwen Zhou; Aiwu Li; Di Zheng; Jianfang Xu; Caicun Zhou 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 278 KB

A phase I study of irinotecan (CPT-11) a

✍ Kakolyris, S; Kouroussis, Ch; Mavroudis, D; Souglakos, J; Kalbakis, K; Agelaki, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Irinotecan (CPT-11) in combination with

✍ Kunihiko Kobayashi; Ayako Shinbara; Mitsuhiro Kamimura; Yuichiro Takeda; Koichir 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 405 KB

Activity of weekly irinotecan (CPT-11) i

✍ Rosa Sánchez; Emilio Esteban; Isabel Palacio; Yolanda Fernández; Isabel Muñiz; J 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 59 KB

Irinotecan and oxaliplatin combination a

✍ Myung Hee Chang; Kyoung Ha Kim; Hyun Jung Jun; Hyo Song Kim; Seong Yoon Yi; Ji E 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 312 KB